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ABSTRACT
There are periods during perinatal development in which specific
nutrients are required for optimal development, and there is growing
evidence that optimal dietary intake of these nutrients, which in-
clude iodine, docosahexaenoic acid, choline, and folate, is impor-
tant. Lessons in how these nutrient effects were identified can help
us to broaden our approaches for finding other critical nutrients: we
are looking for nutrients for which there is a wide range of dietary
intake, that have no or marginal pathways for biosynthesis, and that
are needed by dividing progenitor cells. For some of the nutrients
discussed, such as iodine and folate, the effects in humans are
abundantly clear; for others, animal data are the most convincing.
More human studies need to be conducted. We need a better un-
derstanding of diet and diet supplement intake during pregnancy
and lactation and of whether diets are particularly low in some
nutrients. Also, we need to understand how common genetic varia-
tions influence nutrient requirements during these periods. If we are
going to supplement maternal and infant diets, first we must un-
derstand much more about the risks of having too much of a critical
nutrient. Whatever the limitations of our current state of knowledge,
it is apparent that pregnancy and lactation are periods during which
good nutrition is exceptionally important. The infant is not pro-
tected from the inadequate diet of the mother. Am J Clin Nutr
2009;89(suppl):685S–7S.
INTRODUCTION
The goal of the Experimental Biology Symposium on Maternal
Supplementation (April 2008) was to review all available lines of
evidence, delineate unanswered questions, and suggest a research
agenda to determine whether maternal supplementation with
specific nutrients might be beneficial. Nutrient requirements for
the mother increase greatly during pregnancy, while at the same
time fetal development is especially sensitive to the availability of
some of these nutrients. Although we believed that the fetus was
nourished adequately at the expense of maternal stores and needs,
this series of articles in this supplement issue reviews evidence
that this is not always true and that fetal development can be less
than optimal if certain nutrients are not available during specific
sensitive windows of development.
IODINE
Wehave longrecognized that iodine isoneof thecriticalnutrients
mentioned previously, and the article by Zimmerman (1) examined
currentevidencesupportingthisconclusion.Theiodinerequirement
during pregnancy is greatly increased because the mother synthe-
sizes 50% more iodine-containing thyroid hormone, some of which
is transferred to the fetus; in addition, the mother has increased renal
losses of iodine (2). In areas of the world where seafood is not
a common staple of the diet, maternal iodine deficiency can ad-
versely affect cognitive development of the fetus and of children
(decreasing IQ on average by a dozen points). Zimmerman (1)
noted that it is unclear whether mild-to-moderate maternal iodine
deficiency in humans produces more subtle changes in cognitive
function, because there have been no controlled studies of long-term
outcomes. There are many confounding factors that are difficult to
separate from iodine deficiency, making assessments of the effects
of modest iodine deficiency more difficult. The susceptible time
window, during which dietary iodine is critical, is a relatively long
one. Although providing adequate iodine in mid-to-late pregnancy
improves infant cognitive development, there are greater benefits
when iodine is given before or early in pregnancy (1). The most
common strategy used to deliver iodine to pregnant mothers is
universal salt iodization, but if access to iodized salt cannot be
assured, the World Health Organization has suggested that diet
supplements are appropriate (3).
DOCOSAHEXAENOIC ACID
Docosahexaenoic acid (DHA, 22:6n23) is one of a class of
nutrients for which there is limited capacity for endogenous
biosynthesis, and therefore it is conditionally required in the diet.
Carlson (4) reviewed the evidence for maternal supplementation
with this fatty acid. DHA is important during pregnancy and
lactation because it is the major omega-3 (n–3) fatty acid needed
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to build fetal brain, and the rate of biosynthesis by elongation and
desaturation of precursor fatty acids may be too slow to meet the
requirement. It is interesting that single nucleotide poly-
morphisms (SNPs) in the genes coding for the fatty acid desa-
turases required for D5 and D6 desaturation of fatty acids are
correlated with cognitive benefit derived from human milk (high
in DHA content) compared with formula (lower in DHA) (5).
Carlson noted that, although there are good data from animal
models (6), there are few randomized trials in humans that show
the benefits of maternal DHA supplementation during pregnancy
or lactation for the child. However, Carlson reviewed multiple
observational studies linking higher DHA intake by mothers
with enhanced cognition or visual function in their children.
The susceptible window during which dietary DHA may be
needed to optimize brain development is a relatively long one and
extends from midpregnancy (7) into the first year of life (8). The
most rapid rates of brain DHA accumulation in fetal brain occur
during the last intrauterine trimester and the first year of life (4).
Pregnant women are reducing their intake of DHA, especially in
the United States, in part because of warnings about fish intake
during pregnancy. This is reflected in lower breast-milk DHA
concentrations; in US women, milk DHA concentration is
,0.2% of total fatty acids, whereas in some Chinese women it is
2.8% of fatty acids (4). Two strategies could make more DHA
available for brain development: maternal diet could include
more fish and, where that is not possible, a supplement could be
provided or infant formulas could be supplemented with DHA.
In the last few years, many infant formulas have been modified
to add DHA or other omega-3 fatty acids. Because we are not
sure whether postnatal supplementation can correct fully for
prenatal deficiency, it also seems appropriate to assure an ade-
quate maternal intake throughout pregnancy and lactation.
CHOLINE AND FOLATE
Folateisanessentialvitamin,whereascholineisanotheroftheclass
of nutrients for which there is limited capacity for endogenous bio-
synthesis, and therefore it is conditionally required in the diet. Zeisel
(9) examined the evidence that these nutrients are important for
optimal brain development. Dietary folates, in the form of tetrahy-
drofolates, are essential cofactors for several biochemical reactions
that transfer one-carbon units (10). Choline is required for membrane
synthesis, methylation reactions, and for neurotransmitter synthesis
(11). These nutrients are metabolically interrelated.
Dietary intake of folic acid can be marginal during pregnancy
to the point that some pregnant women can become clinically
folate deficient (12, 13). Dietary intake of choline has not been
carefully described during pregnancy, but we know that the di-
etary requirement is influenced by several very common SNPs in
genes of methyl metabolism (14, 15). Neural tube closure in
humans is disrupted when either of these nutrients is not
available during very early pregnancy (16, 17). In rodent mod-
els, both nutrients are also important later in pregnancy when the
hippocampus develops; maternal dietary deficiency of either
choline or folic acid diminishes neurogenesis and increases
neural cell death in the fetal brain (18, 19). Rats that consume
extra choline give birth to pups that perform better on memory
tests, suggesting that this nutrient’s effects on neurogenesis have
functional significance (20). There are no equivalent studies in
humans.
Two strategies could make more folate available for brain de-
velopment: maternal diet could include more folate and folic acid
and, where that is not possible, a supplement could be provided or
infant formulas could be supplemented with folic acid. Rates of
neural tube birth defects fell by 26% in the United States after
enriched cereal grains consumed by women were fortified with 140
lg of folic acid/100 g of grain (21). All prenatal vitamin supple-
ments contain folic acid, as do infant vitamin supplements and
infant formulas. Two strategies could make more choline available
for brain development: maternal diet could include more foods such
as eggs and liver and, where that is not possible, a supplement could
be provided or infant formulas could be supplemented with choline.
No prenatal vitamin supplements currently contain enough choline
to adequately supplement a mother, but in the past few years many
infant formulas have been modified to add choline. Because we are
not sure whether postnatal supplementation can correct fully for
prenatal deficiency, it seems appropriate to assure an adequate
maternal intake throughout pregnancy and lactation.
USE OF DIETARY SUPPLEMENTS BY PREGNANT AND
LACTATING WOMEN
Picciano and McGuire (22) reviewed diet supplement use in the
United States and found a paucity of data concerning the use of
dietary supplements during pregnancy and lactation. Although use
of dietary supplements in the general US population is high and
growing, demographic, sociologic, and economic factors influence
supplement use. Female supplement users tended to be non-His-
panic white, more educated, and more affluent (23). Thus, in-
dividuals with perhaps the greatest risk for having inadequate diets
were the least likely to take a supplement. Most pregnant women are
advised to consume prenatal vitamin supplements. Picciano and
McGuire found no consistent recommendations concerning dietary
supplement use during lactation, although the American Thyroid
Association recommends that breastfeeding women receive 150-lg
iodine supplements daily. The Institute of Medicine’s most recent
report (24) recommended that lactating women be encouraged to
obtain their nutrients from a well-balanced, varied diet rather than
from vitamin–mineral supplements. Whether recommended or
not, Picciano and McGuire noted that the limited data available
suggest that most pregnant women take supplements.
CONCLUSIONS
There is growing evidence that the fetus and young infant are not
protected from the inadequate diets of their mothers. It appears that
there are periods during development in which specific nutrients
are required for optimal development. Scientists discovered the
requirements for iodine, folate, choline, and DHA for optimal
development because they thought to look at these specific com-
ponents of the diet; there are likely to be many more critical
nutrientswhenwecastabroadernet inourresearch.Lessons inhow
these nutrient effects were identified can help us to broaden our
approachesforfindingmore:weseemtobe lookingfornutrients for
which there is a wide range of dietary intake, that have no or
marginal pathways for biosynthesis, and that are needed by di-
viding progenitor cells.
For some of the nutrients discussed, such as iodine and folate, the
effects inhumansareabundantlyclear;forothers,animaldataarethe
most convincing, with human data not yet at the state at which these
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requirements should be engraved in stone. It is important that these
human studies be conducted as randomized clinical trials because
observational data are subject to confounding, especially when we
are looking for subtle effects. However, while we wait for results
from such studies, it might be costly to ignore these effects of
nutrients and do nothing.
We have enough data on human diets during pregnancy and lac-
tation to recognize that there is widevariation in nutrient intake, and it
wouldbereasonabletoattempttomoveindividualswithlowintakeup
toward the population mean. It is becoming obvious that common
genetic variations influence nutrient requirements. As our un-
derstanding of these SNPs is refined, we can identify women who
appear tobeconsumingenoughofanutrientbutwhoneedtoconsume
more because of a metabolic inefficiency. There may be many more
nutrients that are conditionally essential during pregnancy and lac-
tation. As noted in the series of articles from this symposium, such
SNPs exist in pathways for the biosynthesis of DHA and of choline.
TherearemillionsofcommonSNPsandmanyofthemmust influence
metabolism; it is important that we characterize these soon.
We need to consider the composition of prenatal supplements in
lightofsuchnewdata, justasweneedtoexaminethecompositionof
infant formulas used to substitute for breast milk. We do not know
enough to describe all of the critically needed nutrients for optimal
development,andalthoughweremainrelativelyignorant,wemight
use data on the mean dietary intake of populations and on the
nutrientcompositionofhumanbreastmilkasapproximationsof the
ideal until we know better. Already, we suspect that this approach
can fail us; for example, maternal diets have changed over the last
few decades such that breast milk in the United States is probably
too low in DHA content to assure optimal development of the fetus.
If we are going to supplement maternal and infant diets, we
need to understand much more about the risks of too much of
a critical nutrient. It is possible that the same mechanisms re-
sponsible for nutrient effects on optimal development (eg, gene
expression regulation by DNA methylation) can also result in
unwanted side effects (eg, suppressing expression of a needed
gene). Until we know more, it seems best to limit supplemen-
tation during pregnancy and lactation to levels that humans have
had experience with—perhaps the upper quartile for population
intake. In addition, we do not know the factors that influence
compliance with diet supplement recommendations. At this time,
we fortify the food supply with folic acid because we think that
we cannot attain a level of compliance with supplement recom-
mendations to adequately protect the population.
Whatever the limitations of our current state of knowledge, it is
apparent that pregnancy and lactation are periods during which
good nutrition is exceptionally important. The baby is not pro-
tected from the inadequate diet of the mother. We already know
that a dollar invested in nourishing pregnant and lactating women
results in a manyfold return in better infant outcomes. We are now
uncovering some of the mechanisms responsible. While we are
searching for specific supplements that optimize development, we
should not forget to continue to invest in assuring that pregnant and
lactating mothers have access to a good diet. (Other articles in this
supplement to the Journal include references 1, 4, 9, 22, and 25).
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